Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

被引：0
作者：
Johan Jendle
Jayne Smith-Palmer
Alexis Delbaere
Simona de Portu
Natalie Papo
William Valentine
Stéphane Roze
机构：
[1] Örebro University,
[2] Ossian Health Economics and Communications,undefined
[3] Medtronic International Trading Sarl,undefined
[4] HEVA HEOR,undefined
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Cost; Cost-effectiveness; Type 1 diabetes; Sensor-augmented pump therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1030
页数：15
相关论文
共 50 条
[21]   Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US [J].
Ray, J. A. ;
Valentine, W. J. ;
Roze, S. ;
Nicklasson, L. ;
Cobden, D. ;
Raskin, P. ;
Garber, A. ;
Palmer, A. J. .
DIABETES OBESITY & METABOLISM, 2007, 9 (01) :103-113
[22]   Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial [J].
Azahaf, Salima ;
Beunen, Kaat ;
Van Wilder, Nancy ;
Ballaux, Dominique ;
Vanhaverbeke, Gerd ;
Taes, Youri ;
Aers, Xavier-Philippe ;
Nobels, Frank ;
Van Huffel, Liesbeth ;
Marlier, Joke ;
Lee, Dahae ;
Cuypers, Joke ;
Preumont, Vanessa ;
Siegelaar, Sarah E. ;
Painter, Rebecca C. ;
Laenen, Annouschka ;
Gillard, Pieter ;
Mathieu, Chantal ;
Luyten, Jeroen ;
Benhalima, Katrien .
ECLINICALMEDICINE, 2025, 81
[23]   Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems [J].
Tauschmann, Martin ;
Hovorka, Roman .
EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (06) :943-955
[24]   Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland [J].
Braendle, M. ;
Erny-Albrecht, K. M. ;
Goodall, G. ;
Spinas, G. A. ;
Streit, P. ;
Valentine, W. J. .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (08) :501-515
[25]   An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes [J].
Home, Philip ;
Baik, Sei Hyun ;
Gonzalez Galvez, Guillermo ;
Malek, Rachid ;
Nikolajsen, Annie .
JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (03) :230-240
[26]   Sensor-Augmented Pump Therapy: description of pediatric patients with Type 1 Diabetes Mellitus (T1D) and initial metabolic outcomes [J].
Wong Lam, Carolina ;
Hurtado Navarro, Josefa ;
Fuentes Diaz, Rocio ;
Toro Toro, Elizabeth ;
Reyes Espejo, Barbara .
ANDES PEDIATRICA, 2022, 93 (06) :860-867
[27]   Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective [J].
Marc Evans ;
Jens Gundgaard ;
Brian Bekker Hansen .
Diabetes Therapy, 2016, 7 :809-823
[28]   Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria [J].
Monika Russel-Szymczyk ;
Vasil Valov ;
Alexandra Savova ;
Manoela Manova .
BMC Endocrine Disorders, 19
[29]   Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective [J].
Evans, Marc ;
Gundgaard, Jens ;
Hansen, Brian Bekker .
DIABETES THERAPY, 2016, 7 (04) :809-823
[30]   Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria [J].
Russel-Szymczyk, Monika ;
Valov, Vasil ;
Savova, Alexandra ;
Manova, Manoela .
BMC ENDOCRINE DISORDERS, 2019, 19 (01)
12345